GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » EDX Medical Group PLC (AQSE:EDX) » Definitions » Capex-to-Revenue

EDX Medical Group (AQSE:EDX) Capex-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is EDX Medical Group Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

EDX Medical Group's Capital Expenditure for the six months ended in . 20 was £0.00 Mil. Its Revenue for the six months ended in . 20 was £0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


EDX Medical Group Capex-to-Revenue Historical Data

The historical data trend for EDX Medical Group's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EDX Medical Group Capex-to-Revenue Chart

EDX Medical Group Annual Data
Trend
Capex-to-Revenue

EDX Medical Group Semi-Annual Data
Capex-to-Revenue

Competitive Comparison of EDX Medical Group's Capex-to-Revenue

For the Diagnostics & Research subindustry, EDX Medical Group's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EDX Medical Group's Capex-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, EDX Medical Group's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where EDX Medical Group's Capex-to-Revenue falls into.



EDX Medical Group Capex-to-Revenue Calculation

EDX Medical Group's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

EDX Medical Group's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EDX Medical Group  (AQSE:EDX) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


EDX Medical Group Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of EDX Medical Group's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


EDX Medical Group (AQSE:EDX) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
210-211 Milton Road, Cambridge, GBR, CB4 0WA
EDX Medical Group Plc develops and validates digitally enabled diagnostic products and services to help predict disease risk, inform clinical decision-making and accelerate the development of new medicines in the areas of cancer, heart disease, neurology and infectious diseases.

EDX Medical Group (AQSE:EDX) Headlines

No Headlines